Search

Displaying results 4181 - 4190 of 6951 in total
  1. Drug

    ALKS 29

    go.drugbank.com/drugs/DB05723
    Experimental

    ALKS 29 is a new product candidate for the treatment of alcohol dependence. It is being developed by Alkermes, Inc.

  2. Drug

    AZD-7295

    go.drugbank.com/drugs/DB12724
    Investigational

    AZD7295 has been investigated for the treatment of Hepatitis C.

  3. Drug

    Glyceryl Trioleate

    go.drugbank.com/drugs/DB13038
    Investigational

    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.

  4. Drug

    Surinabant

    go.drugbank.com/drugs/DB13070
    Investigational

    Surinabant has been investigated for the treatment of Smoking Cessation.

    Categories: Cannabinoid Receptor Antagonists, Receptor, Cannabinoid, CB1, antagonists & inhibitors
  5. Drug

    Gisadenafil

    go.drugbank.com/drugs/DB11902
    Investigational

    Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

  6. Drug

    Napabucasin

    go.drugbank.com/drugs/DB12155
    Investigational

    Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

  7. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

  8. Drug

    Piclozotan

    go.drugbank.com/drugs/DB12361
    Investigational

    Piclozotan has been investigated for the treatment of Parkinson's Disease.

    Categories: Serotonin Receptor Agonists, Serotonin 5-HT1 Receptor Agonists
  9. Drug

    Glyceryl Trierucate

    go.drugbank.com/drugs/DB12528
    Investigational

    Glyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.

  10. Drug

    Cerlapirdine

    go.drugbank.com/drugs/DB12229
    Investigational

    Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

    Categories: Serotonin Receptor Antagonists